Orange Book product · Brand (NDA)
VALCYTE
VALGANCICLOVIR HYDROCHLORIDE
At a glance
Aug 28, 2009
Approved
Brand (NDA)
Application
AB
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 28, 2009
17 yr 1 mo ago
Today
Patent 8889109 expires
Listed drug product patent expiration.
Dec 11, 2027
in 1 yr 6 mo
Patent 9642911 expires
Listed drug product patent expiration.
Dec 11, 2027
in 1 yr 6 mo
Pharmaceutical detail
Active ingredient
VALGANCICLOVIR HYDROCHLORIDE
Strength
50MG/ML
Dosage form
FOR SOLUTION
Route
ORAL
TE code
AB
Application
NDA 022257
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2001VALCYTEBrand (NDA)
NDA 021304 · CHEPLAPHARM
- 2026VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 218838 · MICRO LABS
- 2025VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 218027 · SPH ZHONGXI PHARM
- 2024VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 212876 · SOMERSET THERAPS LLC
- 2023VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 216317 · APPCO
- 2022VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 215124 · AUROBINDO PHARMA
- 2022VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 211475 · HETERO LABS LTD V
- 2022VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 210169 · MSN
- 2021VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 205151 · PHARMOBEDIENT
- 2020VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 213306 · GRANULES
- 2020VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 212890 · AJANTA PHARMA LTD
- 2019VALGANCICLOVIR HYDROCHLORIDEGeneric (ANDA)
ANDA 212234 · AJANTA PHARMA LTD
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8889109 | Dec 11, 2027 | in 1 yr 6 mo | Product |
| 9642911 | Dec 11, 2027 | in 1 yr 6 mo | Product |

